Interferon β-Mediated Protective Functions of Microglia in Central Nervous System Autoimmunity

Stefanie Scheu1, Shafaqat Ali2,3,4, Ritu Mann-Nüttel5

  • 1Institute of Medical Microbiology and Hospital Hygiene, University of Düsseldorf, 40225 Düsseldorf, Germany. stefanie.scheu@uni-duesseldorf.de.

Insights

Interferon beta (IFNβ) is a key treatment for multiple sclerosis (MS). This review explores how IFNβ impacts microglia and macrophages in CNS autoimmunity, offering insights into its therapeutic mechanisms in MS and EAE models.

Area of Science:

  • Neuroimmunology
  • Central Nervous System (CNS) Autoimmunity
  • Demyelinating Diseases

Background:

  • Multiple sclerosis (MS) is a chronic CNS inflammatory disease causing demyelination and axonal damage.
  • Interferon beta (IFNβ) is a standard treatment for relapsing-remitting MS (RRMS), reducing disease progression and exacerbations.
  • IFNβ ameliorates experimental autoimmune encephalomyelitis (EAE), a mouse model of MS, but its precise mechanisms in CNS autoimmunity remain unclear.

Purpose of the Study:

  • To review the origin, phenotype, and function of microglia and CNS immigrating macrophages in MS and EAE pathogenesis.
  • To highlight the emerging roles of microglia as IFNβ-producing cells.
  • To examine the impact of IFNβ on microglia in the context of CNS autoimmunity.

Main Methods:

  • Literature review of studies on microglia, macrophages, and IFNβ in MS and EAE.
  • Analysis of existing research on the cellular and molecular mechanisms of IFNβ in CNS autoimmunity.
  • Synthesis of current understanding regarding IFNβ's effects on immune cells within the CNS.

Main Results:

  • Microglia and infiltrating macrophages play critical roles in the pathogenesis of MS and EAE.
  • Microglia are identified as significant producers of IFNβ within the CNS.
  • IFNβ exerts notable effects on microglia, influencing their function in autoimmune responses within the CNS.

Conclusions:

  • Understanding the interplay between IFNβ and microglia is crucial for elucidating MS pathogenesis.
  • IFNβ's complex mechanisms in CNS autoimmunity involve modulation of microglial function.
  • Further research into these molecular mechanisms can inform future therapeutic strategies for MS.